ONCT (Oncternal Therapeutics) Net earnings per share growth this year

ONCT (Oncternal Corp) - company brandmark

Oncternal Therapeutics develops targeted biologics through synergy with oncology centers. Annual EPS fluctuations illustrate the dynamics of this process, where 0.00 represents the current level of the metric. Business prospects rely on the treatment of lymphomas and solid tumors funded by insurance payments. Operational activities are strictly limited by FDA regulations, which reduces the eco-strategy to the proper disposal of biomaterials.

Earnings per share growth in current year: Oncternal Therapeutics Inc (ONCT) for 07/04/2022 - 12/14/2024

Financial and market metric breakdowns for oncternal.com (ONCT)

- stock quotes and analyst forecast:
Summary company analysis:ONCT Oncternal Therapeutics
Signature product of Oncternal Therapeutics

Institutional capital assesses the attractiveness of Oncternal Therapeutics (ONCT) through yield dynamics, where the annual change in earnings per share serves as a leading indicator of performance. This metric measures the percentage shift in EPS relative to the previous year, utilizing market data to mitigate the time lag of official reporting. For the biopharmaceutical sector, such chart volatility signals liquidity risks and the success of clinical trials, determining the asset's ultimate reliability.

Key competitors

Earnings per share growth this year INCY|Earnings per share growth in current year Hutchison MediPharma|Net earnings per share growth this year nuvationbio.com (NUVB)|Earnings per share growth in current year Day One Biopharmaceuticals Inc (DAWN)|MNPR - Earnings per share growth rate in current year|Earnings per share growth in current year Inhibrx Biosciences Inc INBX|I-Mab - Earnings per share growth in current year|FENC - Earnings per share growth in current year|Earnings per share growth rate in current year herontx.com|NVCT: Earnings growth in current year|Net earnings per share change in current year Coherus CHRS|Net earnings per share growth this year CRBP|Earnings per share growth rate in current year Cardiff Oncology CRDF|Net earnings per share growth this year BYSI (BeyondSpring Inc.)|BCAB (BioAtla Corp) - Earnings per share increase in current year|Lixte Biotechnology - Net earnings per share growth this year|Net earnings per one share growth for the current year CTXR (Citius Pharma)|Cellectar - Earnings growth in current year|Earnings per share increase in current year BLRX (BioLineRx Corp)|CANF: Earnings growth in current year|Earnings per share growth rate in current year Aprea (APRE)|Earnings per share growth in current year kaziatherapeutics.com|SLXN: Earnings per share increase in current year|Earnings growth in current year NCNA|Earnings growth in current year Chimerix Inc (CMRX)|Earnings per share growth in current year Cyclacel Pharmaceuticals Inc. CYCC|GTHX (g1therapeutics.com) - Earnings per share trend in current year|KRON: Net earnings per share growth this year|Earnings per share growth rate in current year Kintara Therapeutics Inc|Portage Biotech (PRTG) - Earnings per share growth in current year